Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
One other thing I noticed in the quarterly report was revenues. Anyone else see that? $50,000 big ones at a cost of $2000. Quite a margin. I guess they finally realized that they could actually sell the product to those that want to run trials for new indications. No need to give it away for free huh. These universities or hospitals or whoever it came from, do have that thing you are trying to get for the company. Money. There ARE other ways of getting it besides dilutions or grants. What a novel concept...selling a product.
You beat me to it Happy. Nothing makes sense with anything this company does. Just objectively look at all the points the 3 amigos put out, and see if you can argue them with any effectiveness. I have yet to see any good arguments that justify these clowns being left at the helm. NONE.
I've been questioning the "fast track" I'm Japan for quite some time. Every presentation, I see that Japanese man with his fist raised. Often wonder what twin that's directed to. Same thing with Sosei. Best deal. Jokes. It's a pathetic deal to begin with, and still get nothing finalized. $11 million for 65% of the joint company they will form of ever. Are they just waiting for the IC results? That's the only thing I can think of now. And if so, they better be willing to cough up a lot more than $11 million of the results are good. Or kick them to the curb immediately.
But I'm still "ok" with them. Tomorrows the we'll get em next week day. Will we get news. Will Pluristem sell into any rally. We will wait and see like always. And Happy, there has never been any transparency from day one. And today, we found out why.
Hey Saud and others.
Yes they have little control of the ARS. But they do have control of the fake time frames they put out time and time again. What about the Fukushima and NYBC milestone of 1h17. Both preclinical on animals. No enrolment necessary there. So D, please go back and see if anyone has EVER even attempted to answer that question would you. This one I have asked today hasn't been touched and it is most definitely new. I will put it all in caps so nobody can miss it.
DOES ANYONE THINK THEY MET MOST OF THEIR MILESTONES IN 2017.
You can only run and hide from investors for so long. This was their most thorough thing they have ever said in an update. And even this is a joke. Just some new extended timelines. Say them all you like. Does anyone here even think that these timeframes will be met. You can only cry wolf so many times before people don't believe what you say any more. That day was long ago for me, Just because you put your tail between your legs and actually try to answer some of the many questions we have asked for a long time, doesn't make me feel any better. Worse actually. Because all this time it was there just to string us along.
And yes these were some of the questions i blasted them ALL about in emails. Not just IR. I could care less if they ever respond as I must have got my point across as we have finally got some answers...as horrible as they are. At least they are there...somewhat, better than ever, still crap though. Absolute reason they have never held a CC.
So yes I am upset Happy, that they have done this. And yes D, I do get upset when people try to defend these clowns with essentially zero argument to back up any of these claims. I truly don't comprehend how or why anyone would. I don't. Point after point is raised about these clowns, timeframes are missed by many months and in some cases years. Some don't have an end in sight.
So when the first born clown twin comes out and states they met MOST milestones, it proves my point to a t. They are delusional and have zero ability to take this company anywhere.
I posed the question just last night as to why they would be selling in January via the ATM on days, or the next day, of releasing news. Who needs shorts or a controller when the company is knocking down the share price by selling into news. Pathetic.
If it weren't for the pump to entice the Israeli investors, our 52 week trading range would be within about 30 cents. What Biotech stock can boast that. Usually 2 or 3 plus naggers at one point in their 52 week high and low. Pretty much the epitome of what you call "dead money".
Disappointing is one way to put it. Even go back to the September presentation. They were still saying contract with government 2h17 and initiation of pivotal study of 2h17/1h18. They had to know this was just a hope and nothing more. But I guess they had to have something positive to sucker the Israeli investors in.
Yes IC results are one thing that could help our dismal price. But like I've stated before, what if they're not great? What will that do to the price? Especially knowing no surprises coming in the near term on ARS. And for all that talk of legislation in order to stockpile R18, pathetic. Nothing to do with R18 in the least.
At least we know why they were silent for much of the year, and just kept changing milestones. Nothing to report. Just keep everyone hoping while we remain silent. Almost makes you wish they kept silent. Careful what you wish for I guess.
Still boggles my mind how Zami can say they made most of the milestones in 2017 in In the first part of the update. How does that show any credibility at all. Working hard to reach milestones. Hah!!! Off on the world tour. And I guess he's referring to any news release as being an "unexpected milestone". Again what is that!!!
To those wanting to brag about their $1.10 average cost. Think they're ok because they're still up. Get some cash ready, you may be able to lower that in the coming weeks or months. Maybe once your under water you'll change your tune. But then again, you seem to be cut from the same cloth as many here. So you're "ok" no matter what. And refuse to even attempt to anser serious questions about management and board. LMBO.
Maybe they'll give themselves some more big bonuses this year. Well deserved don't you think. Hopefully they get the boot at the AGM. That's what i hope to see. Twins...jokes.
Exactly. Should have come out now and said 2019 is the new year of the shareholder. Just goes to show why they were selling in January.
It's called reality. Would have saved you a ton of supposed money if you lived in it. LMBOx200,000. Make it to your goal yet. LMBO.
That is just my logical assumption
Here are the milestones from last January. Since DD is not your thing. You think Zami was truthful?
Data readout does selection ARS 1H17
Contract with U.S. Government for ARS 2H17
Initiation of pivotal study ARS NHP 2H17
Data readout phase 1 open label HCT 2H17
Preclinical data Fukushima 1H17
Preclinical data NYBC 1H17
U.S/Europe phase 3 study initiation 1Q17
Japan pivitol study initiation 2H17
Closing on JV deal with Sosei 1Q17
Data from IC multinational phase 2 early 2018
Interim results from Europe phase 3 CLI 2H18-1H19
And at the bottom with milestones for 12 months a couple more.
Initially trial hip fracture
Licensing deal JV with China.
Misses on vast majority of them. Some by 7 months now. So why the delay on preclinical data from Fukushima and NYBC. Having trouble enrolling mice?
But I'm ok with management.
Nope. Need massive Sosei deal to close first. It's fast tracked all right.
Crickets. Go figure. Lmbo. . You think they made most of their 2017 milestones? Surprise milestones. What is that. LMBO. How bout those interim results we just got in HCT. They're safe. Woohooo. How bout a mention of efficacy. Jokes.
Yet you still don't answer any questions. Jokes.
Did you buy any when they were selling in January. Keep the faith EH.
You think they made most of their 2017 milestones. Go to the January one of last year. I think they got on or 2 of maybe 10 or so. Glad you're good with that.
And yes the giant Sosei deal is on the table. Amazing. Can't wait for the fast track in Japan to start maybe next year. Only a three hour delay on that one. That's what good management does. And for a whopping $11 million or so investment to start it up. Wow.
Jokes all around. Including anyone on this board who doesn't answer any question I have posed in the last couple of months. Crickets. Care to try?
Can you believe they think they made most milestones in 2017. Delusional, truly. Thanks for the reply n3. Don't have time to respond right now.
Ain't that the truth. Riddle me this one EichKing. At the end of June 2017, they had working capital of $23.6 million that they stated would take them to end of fiscal year 2019. Here we are, 6 months later, contingency plan still in place, with $41 million including the CHA sale as stated below, but we are still only able to make it to end of fiscal year 2019.
"According to management estimates, liquidity resources as of December 31, 2017, together with the proceeds received from the sale of shares of CHA Biotech Co. Ltd. (“CHA”) after the balance sheet date (See Note 1c) and the issuance of shares under the At Market Issuance Sales Agreement (See Note 6), will be sufficient to maintain the Company's operations into the fourth quarter of the Company's fiscal year 2019. The Company's inability to raise funds to carry out its business plan will have a severe negative impact on its ability to remain a viable company."
Almost double the amount of cash, but yet the same survival date, even though 2 quarters have passed. What gives? We going to expand facilities further in the hopes we are going to be able to sell something one day. A lot of nieces and nephews reaching working age? Some more hires coming from Elbit? Maybe we will become the first company ever with tri-CEO's. Egozi almost has a year under his belt as CFO. Promotion to you as well. And then another 2 million share bonus for all THREE of us. Something doesn't add up.
But like always, nobody will comment. Or state it's the norm in Biotech. Don't know the inner workings. Trials are progressing at a snails pace but progressing nonetheless. No bad news. It's a biotech startup that's been starting up for 15 years. Trials always take longer. Want to get the trial design just right. I've heard ethical concerns with NHP's taking up to a year!!! More excuses than the twins. Pluristem cult is what I say.
But again, I'm good with management and board. Give your head a shake, or a couple bangs on a brick wall if you must, because you're wrong.
Cmon Spidey, Zzatt, JP, Ski, Saud, n3m Anyone. How do you write this one off? Please give a response if you can on any of these points I've brought up. I'd say Allo, but I'd just get a beam me up, or Betty Sue. Or a post of a new show. LMBO!!! I'm sure I'll get quoted tomorrow from one I've just mentioned., but then again, they avoid my questions like the plague.
They had a working surplus of $31 million at Dec 30th 2017. And they reported they sold CHA holdings on January 9th 2018. So approximately $41 million in the bank. Before the CHA sale, enough cash to take them to fiscal year end 19.
So why sell these shares now? Do they not think something this year will increase our share price well above that sale mark? If a deal with NIH or DOD, or anyone was imminent in the least, why sell now? We have IC results due out in April. Why sell now? Interim results in HCT. Why sell now? So many things that are supposed to make 2018, the year of the shareholder. But why sell these shares to raise another million. Is that necessary with all the potential? Or the tons of expected milestones we will hear about in the next 12 months. LMBO. Oh we needed that extra million right now. That one million will take them to the finish line? Or did they think it would be better to fund the world tour this way. Or worse, do they know something we don't that is not on the positive side?
The only way I take this ATM sale is an extreme lack of confidence that this company thinks our price will be any higher in the near to mid term. Are these talks progressing like they state in the "presentations", or just fluff. Or some real reasons for all the missed milestones that we don't want to hear about?
To further the distaste of the ATM, a company can just get ready to sell when any news will be released. Sell on news is the old saying right. At least if you're an insider, you have to report it within 2 days (I believe). A company can wait over 3 months in essence, and not have to report a sale date. And we all know even an insider can legally sell on news like Zami did at 5 bucks on news. Either way it stinks no matter how you look at it. Again, how it's legal is beyond me. Amd that goes for Zami's big win at $5. How many has he bought back since? Jokes.
Yes, you don't get the discount that happens with a raise. But you have zero idea of whether they are selling none, or a boatload at any given time. What might our share price be of it weren't for the sells, especially in the times in question.
They had two dilutions last year alone, and the ATM. Why did they not fill the entire auction then instead? Original price on that one was $1.61. Was raised to $1.67. Why not get your money there instead?
Pathetic in any and all ways I see it. Please try again.
But I'm "ok" with management. These clowns are trying to figure it out as they go and it truly shows.
One thing I find telling in this report.
626,800 shares sold via the ATM in January of this year at an average price of $1.57.
There were only 7 days in January where the price reached $1.57 or above. Jan. 9, 10, 12, 16, 17. And the 23rd and 26th we hit a high of 1.57. The 10th was a high of 1.57 as well.
We announced news on the 9th and the 12th. That's all the news we have heard this year. And upon announcing this news, they sell into the small run these announcements gave shareholders. Truly how is this legal? I would imagine it is, but how I will never know. This ATM is just another way to screw shareholders as they are selling into any measly run we have. Pure garbage. Hopefully some of the proud buyers here bought on one of those days. At least they can feel better their money is going directly into their coffers, to support the world tour.
And I know the chosen one thinks selling via the ATM supports the price, but obviously that's not the case.
I remember some mentioning some sayings like take it while you can. Obviously that is what they did and continue to do.
But I'm "ok" with management.
Only constant is the inability of you or anyone to have any valid point when it comes to the defence of management and their cronies who run this company. Zero, nada, zilch. Just ignore the many valid questions and hopefully they will go away and people can once again be happy with prices at the same, if not lower share prices for the last decade.
Again, glad you're good with the blocks of 10,000 shares you were supposedly buying during the pump. Too bad you didn't listen to long timers on this board. Could have supposedly got them at a much cheaper price, or would be that much closer to your 200,000 supposed goal. LMBOx1000
The days not over yet.
Only 2 days in mid December have we closed this low. Then you have to go all the way pre pump and dump to Sept 15th to see a close like this. This is going to get ugly if we don't get something significant. Again, not the worst thing in this world. Would love to see a price south of a buck going into the AGM. Maybe then we will see the change in management and board that is so obviously necessary.
Average down though. Any day we will get some news. It is time to announce some new shows. Only booked until March. Better do a raise soon so summer tour can be fully funded. Maybe selling via ATM has picked up of late to ensure its success. Maybe they will find some non dilutive funding for this. Grant money should be easy to find for these important endeavours.
Sometimes the eyes are just too glazed over EichKing. Too far into the world of the lemmings. One other thing. Don't forget the ATM. So 3 dilutive events last year, not 2. We will see if that spigot is still open in the next week or two.
I'm not too sure what that advisory committee is supposed to do. Collect a cheque is the one thing I'm sure they do.
I know timeframes can be off for the things you mentioned. But how does one miss 2 targets of more than double the estimate on the two preclinical trials. We are 7 months overdue and there is no enrolment issue when they're using mice. Not normal in any way.
Not a problem MC
So you think management could be more transparent. Why stop there in reality. Look at the twins experience in this field. ZERO. Or the board, the ones who allow these bonuses to be gifted based on a comparison of NOTHING as they admitted. Do you think someone who claims to have experience in Nasdaq companies, including Brainstorm, (a company that would qualify as experience) when the company hasn't even been born yet, raises any questions?
Your questions as to who they should get, I have no idea. There are head hunters everywhere that specialize in this thing. Poach top people for other companies. Ask yourself, when has there ever been anything even remotely close to bringing in anyone with experience to fill any top position. Never. Promotions to inexperienced personnel from within only. Unacceptable.
Now I can understand your opposition to the constant posting that I and others bring. It seems contradictory to wanting your stock to move in the right direction. It is!!! I don't always agree with my other so called two amigos. But I can sure understand their frustration and reasoning for doing so. And I will always encourage and support their justified opinions, as long as there is justification to do so, which there are endless reasons to right now. .
In 2016, we were told 2017 would be our year to see gains. The twins were gifted 4 million shares in 2017, and we were then told 2018 would be our year. Is that acceptable in any way whatsoever? You good with that too? They've had more than half a year to justify these bonuses. But they have failed terribly in every way to do such a thing.
Just look at the inability from anyone here to justify management or board to remain. I have never seen one good argument that states otherwise. Even the so called experts have no rebuttal. Right Spidey. Great insights into trials, but next to zero when It comes to management and board. Feeble attempts at times, but easily shot to pieces. Have you seen otherwise. Diatribe...LMBOx1000 I, like the one who says that, can't even put that word in a proper sentence. And they too have ZERO argument. Just cut and paste.
I just have my small investment here, not the couple hundred grand that some claim to have. Anyone claiming they are trying to obtain 200,000 shares is suspect, to say the least. Most skin I've had in this game is $15 grand. More than I wish I had, but I did have high hopes in this company. Who in their right mind would put 2 to 3 hundred g's in this stock. That's absurd imo. I truly hope nobody here really has that kind of skin in the game, Don't know anyone else's story here in reality, just like I post under one alias and as far as I know, know nobody else on this board.
Have a look at Yahoo. The chosen one here, openly admits to multiple aliases there. So who in their right mind would give any praise whatsoever to such a person? Or worse yet, believe their Lonza, Amgen, next week, interim results in CLI in 2018...any statements they make, Would you give them any credibility whatsoever? But yet they do, and just makes you wonder the motives of them as well.
I spend countless, unpaid hours posting and researching this company. I wish I was paid, as then maybe the wife would be ok with the amount of time I spend on my phone. Or my deteriorating eyesight could be justified a little.
But I DO have a voice. It may not be much, but it's a voice. To quote a lyric from someone in my generation, "you can blow out a candle, but you can't blow out a fire", I will continue to voice my obvious concerns with this management and board, until any of the long time shareholders see the same increase in wealth like the employees and upper management most certainly have. Show some faith in this company you run and buy some shares in the open market!!! Would go a long way don't you think? Nah, we just sell a bunch at $5, and buy an extremely small amount a couple years later. Good job clowns.
So I will end in asking questions directed at anyone. Are you "ok" with inexperienced management or board? Are you "ok" with zero transparency? Are you ok with the a lower price than a decade ago? I am not. And hopefully my "incessant whining" will eventually put a chink in the belieber's armour. Along with anyone else who wants to join the righteous fight.
MC...
What can shareholders do? Vote them out. I'm sure there would be little difficulty at all, finding some higher up executive in some big pharma, that would love the chance to take a company with this so called game changing product to become the behemoth some think this has a chance to be.. It's done all the time in any field. What if they spent those 4 million shares to lure someone away. Don't think someone would love the chance to make those 4 million shares worth a ridiculous amount of money. Making us money along the way.
Voting comes in a few months. Why why why do people think these clowns are ok. Are you ok with them? Why why why would you not want someone with experience in their place. Neither one of them has any. Learning as you go has had its chance to play out and it hasn't worked. Period Why why why do you like being left in the dark. Makes zero sense to me. Or do you think they're "ok" keeping shareholders up to speed.
Do you ever even attempt to answer any questions? Nope. No reasonable explanation to the circus of a company run by the twin clownzz.
Pointless Blue. People just ignore reality. It's "deplorable". Kind of like rural America, or Jonestown. It's cult like really. But I guess that's the real reason some post under multiple alloiases. Turn em into zombies.
Even Spidey refuses to answer any questions regarding management, other than token "don't know the inner workings" or "its biotech". Don't think the cult didn't notice. They just shrug it off still for now anyways. Theyre beliebers. Why no answer to the board member having stuff on his resume that can't be verified. "Ok" with that too I guess. You know the question I posed directly to you a couple times now. Ignored why? Because there is no comeback. Nada, zip zilch. You're search turn up nothing like mine did? It's biotech right?
"Anything under $2 is a steal". LMBO. Wouldn't you have wanted to get in 30% cheaper. I tried to warn you long ago but you were too busy buying your several 10,000 blocks. LMBO. How long before we get "anything under a buck is the new great deal?
But there's nothing to worry about...I'm "ok" with management.
Yes a consideration, just like others. But far from a sure thing. Others have received large funding, we have not. Others have theirs stockpiled already, we have not.
Some think the new legislation had us in mind, I do not. Some think they are secretly running the trials. I do not. Some think all these delays are normal in Biotech, I do not. Some don't mind being left in the dark, hoping they somehow will figure it out. I do not.
Can you imagine what will happen if IC results are less than stellar? Or waiting for ARS to begin for a few more months will do? With their price being as fragile and out of favour with pretty much everyone, what will happen if we have something negative come out?
It is a real possibility, one that should not be taken lightly. The longer this company sits in absolute silence, the worse it gets. How do they not see this is beyond me. Maybe we will get a token 3 page overview of the same garbage we've had year after year in a couple weeks.
Just keep sitting in silence, and continue the tour. Street loves it!!!
But there's NOTHING to worry about...I'm "ok" with management.
Yes no worries anywhere right EichKing. Competition, management, share price...all irrelevant and no correlation to the drip drip drip, down to $1.42.
Nobody else in this world of Biotech stocks, have any clue. They were so impressed by our ARS results we shot up a penny. It stunned every Biotech researcher, analyst to convince their respective companies to jump on board.
Lets just overlook any questions about management like they weren't even directed at them. Or anyone for that matter. Shhhhh!!! They don't exist. If we mention nothing, they will just go away and we can all just be happy with whoever runs this ship. It's Biotech. It doesn't matter. There's always next week or next month, or in the case of Pluristem, next year.
Diatribe. LMBO. Wow we were put in our place weren't we. Everything we have ever said was shot down with that rebuttal. I guess they responded once with the "don't know the inner workings" or "missing milestones is the norm in Biotech," or the best one, "I'm ok with management" he's run companies before so that's good enough for me. Excellent, well thought out points. Amazing responses to the vast amount of valid questions about the leadership of this company, along with the never ending delays. Now they don't have to try and come up with anything to justify those tough questions. Everything is covered whew.
Just gives credence to what we have been screaming from mountain tops. Just too bad it falls on deaf ears. I'm truly hoping this thing keeps dropping before the AGM. Would hopefully be a wake up call to the large investors who's voice could actually change the biggest flaw in our company, management. Under new leadership with actual experience, don't think we would have any problem moving the needle in the right direction for longs. Nobody believes the twins except for the lemmings. Shorts have won for a decade, how bout some bones for the longs. Here's to hoping anyways.
Nothing to worry about...I'm ok with management.
Only YOU can assume like you always do and have the exact same wrong outcome.. You can post it under FDApproved, Disruptive, allogeneic, PLX, or whatever handles you choose over on Yahoo board. You are just making stuff up.
But keep up the good work. You deserve praise for posting under multiple handles. Nothing wrong there huh. No agenda there huh. But like true Lemmings do, they hold on to the hope that somehow there's some truth to what you say, even though there's not. Just look at Lonza. LMBO. They BELIEB!!!
Wow Zami should have took his vast knowledge of first aid kits for cars, and re-engineered them a little bit to survival kits. Maybe then, Pluristem's price would be moving in the right direction. Then, maybe I could see a value to having him run the ship. A big maybe, but a maybe.
Hi Happy,
It is just a reference to Justin Bieber and his tween fans, the Beliebers. They love him no matter what they say or do. Pretty fitting IMO.
As for the critics concern over Chinese protection of IP. If there was a concern at all from Pluristem, why would they try to begin with, or continue to. Or why would anyone partner with the Chinese for that matter. Doesn't fly imo.
Don't worry. Didn't miss much like normal. Just ignored any question directed at him like always, and token name calling. You should be glad you didn't see the names he called people. I know how you dislike that sort of thing.
Here's the article in full that FDA mentions. Please feel free to chime in and defend management's and FDA's explanation of Chinese government policy. Imagine we will hear silence just like any question regarding the mismanagement of this company. Just keep saying it can't be true, or it's the norm in Biotech. I trust management that it WAS Chinese policy. They never make anything up. They're accountable and trustworthy people. As long as they keep doing shows, we know they're working hard. That's why our tute ownership levels are so high. I BELIEBE with a hand to the head as you fall to the floor.
China will soon overtake the United States as the biggest foreign investor in Israel.
That was the astonishing prediction made by the Jerusalem Post in December. In 2016, Chinese investment in the Jewish state reached a record US$16.5 billion, according to Thomson Reuters.
Driving this are Chinese companies eager to invest in high-technology and Internet startups, of which Israel is one of the world centers. Historically, it has been American and European capital that invested in them and took them public. In Europe, 101 Israeli firms have launched IPOs and, in the United States, 272.
Last September, Sisram Medical did an IPO in Hong Kong, becoming the first Israeli hi-tech firm to go public on a Chinese stock exchange. Fosun Pharmaceutical owns a controlling stake in the firm; Fosun is owned by mainland tycoon Guo Guangchang.
More Israeli firms will follow the example of Sisram Medical and list in China. An estimated 120 hi-tech Israeli firms have Chinese investment.
In March, many Chinese companies will attend the GoforIsrael Conference at the Hilton Hotel in Tel Aviv, to meet dozens of bio-tech, fintech, ag-tech and life sciences firms. Chairman of the conference is Ronnie Chan, chief of Hang Lung Properties. He is one of the key speakers, together with Chen Shuang, chief executive of China Everbright.
This change reflects several factors – a surplus of capital among Chinese companies and individuals: their favorable view of the ‘startup’ nation and of Jewish people as among the most gifted in the world; and the warm welcome given by Israel, often warmer than in the US and some European countries.
The Middle East conflict and the rights of the Palestinians are not an issue in the Chinese media or public, as they are in the US and Europe.
A milestone in Sino-Israel high-technology cooperation came last December 19, with the official inauguration in Shantou of the Guangdong Technion-Israel Institute of Technology, a joint venture between Shantou University and Technion. Hong Kong billionaire Li Ka-shing attended the event.
Technion Institute of Technology is the MIT of Israel. It is the oldest university in Israel, set up in 1912, 36 years before the Jewish was re-established. The Guangdong site is only its second branch outside Israel.
In 2013, Li donated US$130 million to Technion. A large part of the money came from the profits he made from the IPO of Waze, a GPS-based map software company, in which he held a 11 percent stake. His was the largest donation ever made to Technion and one of the biggest to any Israeli academic institution. Li has been the pioneer of Chinese investment in Israel.
The cornerstone-laying ceremony for the new institution was held in December 2015; in attendance was Shimon Peres, ninth president of Israel. In his address, Technion President Professor Peretz Lavie said: “This partnership, which combines the spirit of Israeli innovation with the power of China, will benefit all parties – the Technion and the University of Shantou, Israel and China – and will give a significant boost to the Chinese education system. The outcomes of this historic project will affect the whole of humanity.”
Chinese firms are also investing in other sectors in Israel. In the major sea port of Ashdod, China Harbour Engineering is building a new pier at a cost of US$1 billion. Five state-owned Chinese construction firms are building thousands of new homes in Israel; each can import 1,000 workers.
In 2017, a record 185,000 Chinese tourists visited Israel, an increase of 46 percent over a year earlier.
The Israeli government and big business welcome this inflow of Chinese money, because it brings new investment and reduces the country’s economic dependence on the United States and Europe.
But not everyone is so supportive. China is a major exporter of arms; its customers include countries and organizations in the Middle East hostile to Israel, including Syria, Iran and Yemen. Its short-range missiles and rockets delivered to these countries have reached Hizbullah in Lebanon and Hamas in the Gaza Strip. Beijing has not used its considerable diplomatic weight to work actively for a peace settlement in the Middle East.
Two Chinese bids to buy Israeli insurance firms failed because of regulatory opposition; these companies manage money of the public and require closer official scrutiny than buying a high-tech start-up or manufacturing firm.
Critics also question whether China will protect the intellectual property rights of Israelis and Israeli companies.
For the moment, however, this opposition is in a minority. This year and next the flood of Chinese investment into Israel will continue.
Your post confirms that it had absolutely nothing to do with Chinese policy don't you think. Why would they go to these shows if they can't invest due to government "regulations". Or how are they set to become the biggest investor in Israel. More likely the Chinese companies explanation of bailing after doing their DD was right after all. Or maybe they finally got the chance to meet the twins in person, and ran for cover.
You can't in one breath, blame Chinese policy for the failed partnership, then post something extremely contradictory. But yet you do. Whatever fits your agenda.
With any luck, maybe the next suitor will come while they're on vacation or on the world tour. Let someone else from Elbit give it a go. Remember, experience isn't necessary in this field.
I'm ok with management though. I'm Justin Belieber!!!
We'll get em next week. I'm good with management. Im a belieber.
I would doubt it. Given the novice status they put in their bio, just shows the lack of investigation they most likely do. Really how easy is it for just about anyone to get an article with coverage as this one has.
Well the DOD has yet to test anything. It will run in parallel with other trial. So we are dead in the water until then. HCT will come one day, month, year.
Just wish something would give. We are up 1.3%. Woohooo. I still hope but it seems to fade more and more, especially when I think about the circus of clowns.
Look at that. While I'm writing this comes out. Just an FYI on the writer. On her Twitter account it says "novice to the world of drugs". Followed by 199.
Would rather a prominent analyst reposting on this. But good exposure nonetheless.
Come the weekend, we will have passed the 9 month mark between the completion of the ARS dosing study and the silence that has followed since.
As a time frame for reference, it took 7 months between completion of mouse trial to the announcement they will be conducting dosing trial.
This delay is agonizing to say the least. Spidey had mentioned the possibility of ethics or trying to get the design perfect. Not too sure I'm agreeing with that explanation. Like I said before, an announcement that they will be proceeding does not need either of these. Really the only thing we ever hear are terms like discussing, advancing, and progressing when it comes to this trial. The DOD was encouraging, but since zip.
This dosing trial and the results we have seen, were pretty much a non event when it comes to investor interest and of course, price. I was truly surprised of the lack of this. We closed 1 penny higher than the previous day, with volume of 1.3 million. Not exactly stellar. What was it that big investors, analysts, people with vast more resources than most, see in this that trial that basically just made this a non event. I think it surprised the company also, as a week or two later Zami did a video that seemed like they were just trying to put something out there because of this lack of interest. Kind of like, did you not see this great release we just had.
We can try to assess the merits of the results we have. Obviously the street wasn't impressed in the least. Spidey has been great in helping to explain the results. I'm sure many biotech stock experts have seen the results as well, along with other things this company has on the go. Big question is why are they not impressed? What do they see that we don't? And now, why this continued delay with nothing being said except a blurb in presentations.
If it's the funding of this that's the holdup, just do it for free like you have the others. Supply what, 300 to 500 doses that cost you what? Even at $7 grand a dose which was a number I seem to recall, you're looking at $3.5 million. I really can't see it being anywhere close to that as I would think one run in a bioreactor would make enough. But even if it was, getting this show on the road seems imperative imo.
Again, like always, I just wish the company would talk to us in a way other than presentations. Even give a scripted interview like you have in the past. The thing too with CC's that is beneficial, is it puts it on record what they say. Makes them have to be accountable for what they say. Maybe that's the reason they fear them so much.
Just give us something really. I can now say...
We'll get em next month.
We'll bring our manufacturing technology to market after others have tried and become successful. Why take the risk of meeting the demands of all those that will be needing commercial quantities in the very near future. Manufacturing is just too risky. You have to build a plant and get it certified you know. Give that one to the big boys. We'll stick with the much safer trial route.
I have seen the light too. I AM good with management. Can't wait for the silent to come out and praise me and my posts. I'm on board!!! This Biotech world is amazing. Zzatt you were right. Anything under $2 IS a steal. Just wish I bought closer to $2 or even just a bit above like you did. Please advise us all again on the next run so we know when to buy. I'm on board with your strategy!!! TIA.
Point taken. So I will leave Zzatt's option of a hundred bagger on the table. Just make it a hundredth of the shares. Isn't that the goal of investing. To be down that much after a decade. I must be wrong on everything. Maybe I should start being ok with management too.
How could they do that. I thought competition stood still in this field. We are supposed to be the only cell manufacturing company that can make commercial quantities at a competitive cost and scale. And here I thought nobody would want to think of a way to meet the obvious growth this sector will have. It was already created a decade ago so why would any company with deep pockets want to try and figure out a way. Or how could they succeed at it? But but but...we have the patents. And we built a facility that took two years off our product development time. Not fair. Didn't even see this coming. What a shock!!!
Steadfast...steadfast in their inability to take this to the next level, or to increase shareholder wealth. Steadfast in ensuring their own pockets are filled with cash and shares. It's biotech remember!!! Market rules don't apply here. LMBO!!!
Excellent post EichKing. Novel...you mean a book right. LMBO. Claims that the same things over and over are posted is not the case much of the time. New revelations are brought up quite often. Just get ignored though. Because it's the same management bashing. Or the milestones that never happen, with just more months added on to the miss. Needs to be remembered as things get forgotten as to the length of these many delays. How long have we now been waiting for ANY milestone to happen?
What would happen in the real world, not Biotech apparently, if someone found something on your resume that seemed to be fictitious? Give them half a million shares? Or would you get canned. But I guess this is the norm in Biotech. Credibility or accountability are irrelevant in this field.
As for Tesla. Not really a good comparison at all on a company to company basis. But you can have a look at investor sentiment though. They don't have the market cap for how they are doing right now. It's about what could happen in the future. They have to get cars on the road for many reasons, even if it means running at huge losses at the rate they do.
Changing climate for one. Gas stations everywhere, but how many charging stations. Infrastructure has to be built to make the adoption of this product more viable to the average consumer. How much revenue will start happening with regards to maintenance, service, parts, especially as these cars get older and more of them on the road? Economies of scale will eventually allow them to reduce costs, either lowering price or improving margins. Would likely think their plan would be to keep getting more of these cars on the road than turning a profit for the foreseeable future.
So that is what has given them the generous market cap. Investors believe this as the future. And being the first company with only electric vehicles, has given investors hope that they will gain more and more market share each year and eventually may come out As a giant this growing market.
Our price clearly indicates what investors think of the future value of this company. If investors or anyone following this company are forever being mislead on milestones time and time again, don't you think trust in the company as a whole would erode. Obviously it has. Traveling circus has yet to prove anything to make big investors think the future potential is worth the huge risk.
And maybe we will get that 10 bagger Zzatt claims. Too bad we'll only have 1 tenth the number of shares. Don't think we'll get that hundred bagger. An RS of that size would be excessive. LMBO.
And for the running to the defence of Spidey, spot on. Funny though HB will run to the defence of you know who as well. For being so distraught on any name calling towards the one poster, it's strange that they always defend one of the worst culprits. But I guess they're on the right side of the fence in the feeble points they try to make. Or the inability to make any credible argument when it comes to our stellar management and board.